Morusin Suppresses Pancreatic Cancer Cell Proliferation and Migration by Targeting SLC6A12 to Inhibit NF-κB and

Wenyan Yang1,2, Wei Zhu3, Zhiyang Yao1,2

  • 1College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, China.

Abstract

Insights

Morusin demonstrates significant anticancer effects against pancreatic cancer by inhibiting cell proliferation, migration, and invasion. It also induces apoptosis and targets SLC6A12, offering potential as a novel therapeutic agent.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Pancreatic cancer has a poor prognosis, necessitating new therapeutic strategies.
  • Morusin exhibits known anticancer properties across various cancer types.
  • This study investigates Morusin's efficacy and mechanisms in pancreatic cancer.

Purpose of the Study:

  • To evaluate the anticancer effects of Morusin on pancreatic cancer cells.
  • To elucidate the molecular mechanisms underlying Morusin's anti-pancreatic cancer activity.
  • To identify potential therapeutic targets for Morusin in pancreatic cancer treatment.

Main Methods:

  • Assessed Morusin's impact on pancreatic cancer cell proliferation, colony formation, migration, and invasion.
  • Analyzed cell cycle progression and apoptosis induction following Morusin treatment.
  • Utilized RNA sequencing (RNA-seq), RT-qPCR, and Western blot to identify and verify key genes and pathways.

Main Results:

  • Morusin significantly inhibited pancreatic cancer cell proliferation, migration, and invasion.
  • Morusin induced apoptosis and disrupted cell cycle progression in pancreatic cancer cells.
  • Morusin modulated SLC6A12 expression and inhibited NF-κB and β-catenin signaling pathways.

Conclusions:

  • Morusin exhibits potent anti-pancreatic cancer activity.
  • Targeting SLC6A12 and associated signaling pathways are key mechanisms of Morusin's action.
  • Morusin shows promise as a potential therapeutic agent for pancreatic cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K